8
• Product combinations (bed frame, mattress, side rails etc.).
• Extent of tissue damage (if any).
• Entrapment.
• Patient falls.
• Small adults (and children).
• Patients who have reduced capacity and are agitated and/or restless.
• Patients with burns.
• Unauthorised people with access to the controls.
4.3 Contraindications
Patient conditions for which the application of pressure relief on an alternating
mattress system is a contraindication are as follows:
• Cervical or skeletal traction.
• Unstable skeletal fractures.
• Unstable spinal injury.
• Exceeds maximum patient weight of the mattress.
• Gross Oedema (when using alternating mode only).
Other contraindications may be relevant which are specific to the patient or care
environment.
4.4 Training
If these instructions for use are not deemed sufficient and the need for
training is required please contact your distributer who will be able to define
the intention and outcomes of any necessary training, who should attend, its
duration and any potential costs involved.
4.5 Biocides
Support surface covers contain a anti-fungal agent to control microbial
deterioration. The active ingredient is 3-iodo 2-propynyl butylcarbamate. The
active ingredient is fully encapsulated within the polymer coating. There are
no special handling requirements.
This product does not contain any Nano-materials and all components are
latex free.
Summary of Contents for DeVilbiss Healthcare Theia
Page 1: ...Dynamic System Instructions for use...
Page 29: ...29...
